{"id":9377,"date":"2024-11-01T11:04:02","date_gmt":"2024-11-01T18:04:02","guid":{"rendered":"https:\/\/www.breakthrought1d.org\/pacificnorthwest\/?p=9377"},"modified":"2026-05-21T17:11:32","modified_gmt":"2026-05-21T17:11:32","slug":"device-studies-cgms","status":"publish","type":"post","link":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/","title":{"rendered":"Device Studies: CGMs"},"content":{"rendered":"<p>Research into better CGMs is booming! Many different companies are looking at ways to make <a href=\"https:\/\/www.breakthrought1d.org\/daily-management\/t1d-technology\/cgms\/\">CGMs<\/a> fit more seamlessly into the various lifestyles of people with diabetes \u2013 smaller size, longer wear-times, different sampling\/insertion technology, and dual glucose-ketone sensing are some of the changes on the horizon.<\/p>\n<p><em><strong>If you would like to contribute to the development of some of these new CGMs by trying them out, please consider participating in a clinical trial!<\/strong><\/em><\/p>\n<p>Rainier Clinical Research Center in Renton has several CGM trials currently enrolling, from a variety of companies: Biolinq, Abbott, Roche, and Dexcom. The studies for Biolinq, Abbott, and Dexcom are all home-use studies. The study for Roche involves three in-person sampling visits.<\/p>\n<p>Interested?<\/p>\n<ul>\n<li>Email: <a href=\"mailto:recruitment@rainier-research.com\">recruitment@rainier-research.com<\/a><\/li>\n<li>Phone: 888-478-8343<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Research into better CGMs is booming! Many different companies are looking at ways to make CGMs fit more seamlessly into the various lifestyles of people with diabetes \u2013 smaller size, longer wear-times, different sampling\/insertion technology, and dual glucose-ketone sensing are&hellip;<\/p>\n","protected":false},"author":1317,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ep_exclude_from_search":false,"publish_on_app_meta":"True","iawp_total_views":11,"footnotes":"","_members_access_role":[],"_members_access_error":"","bt1d_storytelling_post":false,"bt1d_storytelling_more_posts":[]},"topics":[31,16,122],"class_list":["post-9377","post","type-post","status-publish","format-standard","hentry","jdrf_topic-clinical-trials","jdrf_topic-research","jdrf_topic-t1d-support"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Next-Gen CGM Device Studies | Breakthrough T1D Greater Northwest<\/title>\n<meta name=\"description\" content=\"Rainier Clinical Research Center is enrolling for multiple continuous glucose monitor (CGM) clinical trials in Renton, WA. Test upcoming home-use and in-clinic sensors from Dexcom, Abbott, Biolinq, and Roche.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Next-Gen CGM Device Studies | Breakthrough T1D Greater Northwest\" \/>\n<meta property=\"og:description\" content=\"Rainier Clinical Research Center is enrolling for multiple continuous glucose monitor (CGM) clinical trials in Renton, WA. Test upcoming home-use and in-clinic sensors from Dexcom, Abbott, Biolinq, and Roche.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Northwest Chapter\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/breakthrought1dHQ\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-01T18:04:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-21T17:11:32+00:00\" \/>\n<meta name=\"author\" content=\"Breakthrough T1D Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@breakthrought1d\" \/>\n<meta name=\"twitter:site\" content=\"@breakthrought1d\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Breakthrough T1D Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/\"},\"author\":{\"name\":\"Breakthrough T1D Author\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#\\\/schema\\\/person\\\/d91bebaf8f6259d18f7a0d24d101e6e6\"},\"headline\":\"Device Studies: CGMs\",\"datePublished\":\"2024-11-01T18:04:02+00:00\",\"dateModified\":\"2026-05-21T17:11:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/\"},\"wordCount\":126,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/\",\"name\":\"Next-Gen CGM Device Studies | Breakthrough T1D Greater Northwest\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#website\"},\"datePublished\":\"2024-11-01T18:04:02+00:00\",\"dateModified\":\"2026-05-21T17:11:32+00:00\",\"description\":\"Rainier Clinical Research Center is enrolling for multiple continuous glucose monitor (CGM) clinical trials in Renton, WA. Test upcoming home-use and in-clinic sensors from Dexcom, Abbott, Biolinq, and Roche.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/2024\\\/11\\\/01\\\/device-studies-cgms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Device Studies: CGMs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#website\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/\",\"name\":\"Greater Northwest Chapter\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BT1D-favi.png\",\"contentUrl\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BT1D-favi.png\",\"width\":400,\"height\":400,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/breakthrought1dHQ\",\"https:\\\/\\\/x.com\\\/breakthrought1d\",\"https:\\\/\\\/www.youtube.com\\\/@breakthrought1d\",\"https:\\\/\\\/www.instagram.com\\\/breakthrought1d\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@breakthrought1dhq\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/greaternorthwest\\\/#\\\/schema\\\/person\\\/d91bebaf8f6259d18f7a0d24d101e6e6\",\"name\":\"Breakthrough T1D Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/671a28dc8d852432a8ab73f6c4aa3fa4daaf67bf2bda182c96c6bc7c78461c21?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/671a28dc8d852432a8ab73f6c4aa3fa4daaf67bf2bda182c96c6bc7c78461c21?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/671a28dc8d852432a8ab73f6c4aa3fa4daaf67bf2bda182c96c6bc7c78461c21?s=96&d=mm&r=g\",\"caption\":\"Breakthrough T1D Author\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Next-Gen CGM Device Studies | Breakthrough T1D Greater Northwest","description":"Rainier Clinical Research Center is enrolling for multiple continuous glucose monitor (CGM) clinical trials in Renton, WA. Test upcoming home-use and in-clinic sensors from Dexcom, Abbott, Biolinq, and Roche.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/","og_locale":"en_US","og_type":"article","og_title":"Next-Gen CGM Device Studies | Breakthrough T1D Greater Northwest","og_description":"Rainier Clinical Research Center is enrolling for multiple continuous glucose monitor (CGM) clinical trials in Renton, WA. Test upcoming home-use and in-clinic sensors from Dexcom, Abbott, Biolinq, and Roche.","og_url":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/","og_site_name":"Greater Northwest Chapter","article_publisher":"https:\/\/www.facebook.com\/breakthrought1dHQ","article_published_time":"2024-11-01T18:04:02+00:00","article_modified_time":"2026-05-21T17:11:32+00:00","author":"Breakthrough T1D Author","twitter_card":"summary_large_image","twitter_creator":"@breakthrought1d","twitter_site":"@breakthrought1d","twitter_misc":{"Written by":"Breakthrough T1D Author","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/#article","isPartOf":{"@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/"},"author":{"name":"Breakthrough T1D Author","@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#\/schema\/person\/d91bebaf8f6259d18f7a0d24d101e6e6"},"headline":"Device Studies: CGMs","datePublished":"2024-11-01T18:04:02+00:00","dateModified":"2026-05-21T17:11:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/"},"wordCount":126,"commentCount":0,"publisher":{"@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/","url":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/","name":"Next-Gen CGM Device Studies | Breakthrough T1D Greater Northwest","isPartOf":{"@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#website"},"datePublished":"2024-11-01T18:04:02+00:00","dateModified":"2026-05-21T17:11:32+00:00","description":"Rainier Clinical Research Center is enrolling for multiple continuous glucose monitor (CGM) clinical trials in Renton, WA. Test upcoming home-use and in-clinic sensors from Dexcom, Abbott, Biolinq, and Roche.","breadcrumb":{"@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/2024\/11\/01\/device-studies-cgms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/"},{"@type":"ListItem","position":2,"name":"Device Studies: CGMs"}]},{"@type":"WebSite","@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#website","url":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/","name":"Greater Northwest Chapter","description":"","publisher":{"@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#organization","name":"Breakthrough T1D","url":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#\/schema\/logo\/image\/","url":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BT1D-favi.png","contentUrl":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BT1D-favi.png","width":400,"height":400,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/breakthrought1dHQ","https:\/\/x.com\/breakthrought1d","https:\/\/www.youtube.com\/@breakthrought1d","https:\/\/www.instagram.com\/breakthrought1d\/","https:\/\/www.tiktok.com\/@breakthrought1dhq"]},{"@type":"Person","@id":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/#\/schema\/person\/d91bebaf8f6259d18f7a0d24d101e6e6","name":"Breakthrough T1D Author","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/671a28dc8d852432a8ab73f6c4aa3fa4daaf67bf2bda182c96c6bc7c78461c21?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/671a28dc8d852432a8ab73f6c4aa3fa4daaf67bf2bda182c96c6bc7c78461c21?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/671a28dc8d852432a8ab73f6c4aa3fa4daaf67bf2bda182c96c6bc7c78461c21?s=96&d=mm&r=g","caption":"Breakthrough T1D Author"}}]}},"_links":{"self":[{"href":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/wp-json\/wp\/v2\/posts\/9377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/wp-json\/wp\/v2\/users\/1317"}],"replies":[{"embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/wp-json\/wp\/v2\/comments?post=9377"}],"version-history":[{"count":0,"href":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/wp-json\/wp\/v2\/posts\/9377\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/wp-json\/wp\/v2\/media?parent=9377"}],"wp:term":[{"taxonomy":"jdrf_topic","embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/greaternorthwest\/wp-json\/wp\/v2\/topics?post=9377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}